about
Single dose intravenous propacetamol or intravenous paracetamol for postoperative painSingle dose propacetamol or IV paracetamol for postoperative painSingle dose intravenous paracetamol or intravenous propacetamol for postoperative painThe internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomographyPosttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNAA novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activityCockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodelingThe bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humansThe role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.Prokaryotic expression, purification and characterization of human cyclooxygenase-2.Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.Cellular mechanisms of estradiol-mediated sexual differentiation of the brain.Tilapia hepcidin 2-3 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4DMeasurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry.Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysisNonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health StudyCyclooxygenase-2 inhibitors in ginger (Zingiber officinale)Insulin/FOXO signaling regulates ovarian prostaglandins critical for reproduction.Genome sequence of the filamentous soil fungus Chaetomium cochliodes reveals abundance of genes for heme enzymes from all peroxidase and catalase superfamiliesInfluence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults.Lack of association between COX-2 8473T>C polymorphism and breast cancer risk: a meta-analysis.Over-expression of COX-2 mRNA in colorectal cancer.Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulationHow it's made: organisational effects of hormones on the developing brainEffect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease.Analysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancer.Ortho-carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitorsCpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologiesLysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinomaCyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinomaCyclooxygenase (COX) Inhibitors and the Newborn Kidney.Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkersInhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cellsCOX-2 Inhibition Reduces Brucella Bacterial Burden in Draining Lymph Nodes.Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.
P2860
Q24235989-5FA55777-2F3A-4FA4-8609-930DA5D74881Q24243465-3F9BD36E-26F4-44F3-AC92-AFE07CB9DA25Q26471934-B440F5EF-7B25-40A1-A505-9A9AFC4F7486Q27333495-ECB61FFA-75AF-4463-92B0-71B58EB9C7E3Q28114829-BEB67C4F-177D-4421-98A8-B5BB7C5159EDQ28200568-ABEC81B7-3839-41CC-8BCF-47F3EEBFED5CQ28245824-B5DCEE05-25B8-4D75-82D4-1C2446034E1FQ28540582-489A26E7-DC17-432C-9E48-4060AA5D1462Q28546991-C6CE369A-2494-46F7-A93D-D9EF7CA32A8DQ33249461-8EE6BFEE-C1F6-4011-AA20-59FBCFD04EF1Q33655485-0268513A-F3CE-4509-916B-BA23ADB6D295Q33737469-E0A53BAA-6299-4BD5-BEBD-12FA3CE9350FQ33783981-8CCDCD40-B9D7-42D3-97C5-38BE93FC7D78Q33820704-C508ED76-7AA3-43CB-B94F-4C9E578D078CQ34139520-4993F1E1-2044-4DF0-9064-DF24E39F3A14Q34155303-46FECD66-1CEC-46B9-8494-12921D9FECFEQ34158845-69F8F3DE-9D10-43D2-B047-BC10621344A8Q34333203-FC6BB326-EE52-4FDF-BF62-0A77435E6D47Q34381634-3F274EE7-E85A-4D98-B4E3-22979B012CC6Q34479697-5278274E-5E0B-475C-9364-6304ED5BB887Q34518533-F4C20F44-217A-4217-AA2F-8F758C744EE6Q34541362-36512286-E924-46C4-A1FE-3B5AC14C4F9EQ34720131-3588A524-6608-4EAF-A6B4-3182683FE284Q34721693-B702020D-525C-47FC-BA34-C6E530603BF0Q35079511-42DEEF23-5D74-4371-BDB4-D542BAD61011Q35176423-D350A598-B060-40BF-9235-AC167F7F8267Q35205599-621F00F7-1720-4CF4-8DA5-B07E14D51133Q35965141-56492282-DB45-4150-9AF7-F5FCD9CD1F3DQ36085628-04F8FC80-B64F-4C6F-8953-9E4D16F4752FQ36129926-322FC43F-62A8-4681-B3B1-0269407DDBF4Q36378325-CD8F1C17-0D42-4CCC-BDF3-7560383E965DQ36629543-614DD9B7-B2F6-4994-A722-D04C97B9CFC6Q37137675-B9FE1EF8-A9AD-4736-8DC5-47A316C82020Q37149546-0CDA0640-46BD-4191-BB47-B727CBB1E496Q37275704-079D8F02-FA12-44B9-A883-7FEE1814F05FQ37277333-CBFB0EC1-1974-421F-87B7-BE7543F410ABQ37326197-F73B9F5D-A482-475A-8B1A-6D3201864711Q37431170-6CDA00F4-19DD-43C6-88CD-583563F476A9Q37492107-110C7578-E31A-4385-BD8D-87C72ADD4951Q37621036-DD1319C0-5532-420C-BC43-616046FDBB8D
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The cyclooxygenases
@ast
The cyclooxygenases
@en
The cyclooxygenases
@nl
type
label
The cyclooxygenases
@ast
The cyclooxygenases
@en
The cyclooxygenases
@nl
prefLabel
The cyclooxygenases
@ast
The cyclooxygenases
@en
The cyclooxygenases
@nl
P2860
P3181
P356
P1433
P1476
The cyclooxygenases
@en
P2093
Daniel L Simmons
N V Chandrasekharan
P2860
P2888
P3181
P356
10.1186/GB-2004-5-9-241
P407
P577
2004-01-01T00:00:00Z
2004-08-27T00:00:00Z